Welcome to our dedicated page for Reflect Scientfc news (Ticker: RSCF), a resource for investors and traders seeking the latest updates and insights on Reflect Scientfc stock.
Reflect Scientific, Inc. (RSCF) issues frequent news updates that highlight its activities in cryogenic cooling, ultra-low temperature freezers, and advanced refrigeration technologies. Company announcements cover product orders, installations, patents, cost initiatives, and market transitions, offering insight into how Reflect Scientific operates across biotechnology, pharmaceutical, life sciences, transportation, and data center markets.
Recent news has featured multi-unit installations of advanced liquid nitrogen (LN2) freezers for pharmaceutical clients, follow-on orders for the B-90 blast freezer from biopharmaceutical and cold-chain logistics customers, and new contracts for high-performance freezers with international biotech and pharma organizations. These updates provide detail on how the company’s systems are used for vaccine storage, biopharmaceutical preservation, and other temperature-critical applications.
Reflect Scientific also publishes news on strategic and financial developments, including revenue growth tied to Cryometrix ultra-low temperature freezers and solvent chillers, cost-saving programs that use artificial intelligence and contract manufacturing, and transitions among OTC market tiers. In addition, the company reports on patents and initiatives related to data center and AI cooling, such as cryogenic systems for computer rooms and high-density computing environments.
Investors and industry observers can use the RSCF news feed to follow contract wins, product deployments, patent milestones, and operational changes that shape Reflect Scientific’s role in life sciences, cold chain logistics, and IT infrastructure cooling. Regular updates help readers track how the company’s cryogenic technologies are being adopted across its target markets.
Reflect Scientific Inc. (OTCQB: RSCF) has secured a $225,000 order for its advanced blast freezing systems from a major Asia-based BioPharma company. This marks the eighth follow-on order from this client, indicating full adoption and standardization of Reflect Scientific's freezing technology. The order demonstrates the company's strong position in the global biotech market and the reliability of its products.
CEO Kim Boyce highlighted that this repeat order validates the superior performance and cost-effectiveness of their freezer systems. The sales from this order will be reflected in Reflect Scientific's third quarter 2024 financial results. This development signals positive momentum for the company as it expands its market presence and strengthens relationships with key industry players in the pharmaceutical and biotechnology sectors.
Reflect Scientific, Inc. announced sales of $105,000 from the L-80 MAX and L-80 Lite chillers, revolutionizing aluminum heat treatment in aerospace manufacturing. These chillers offer efficiency, precision, and safety, accelerating the quenching process and enhancing component durability. The success in aerospace opens opportunities for other industries. Reflect Scientific Inc. is actively exploring new sectors for their cooling technology.
Reflect Scientific Inc. (Symbol: RSCF) secured a $550,000 sale with a major biopharmaceutical company for its advanced freezing solutions. The sale includes multiple cutting-edge freezer systems shipped in the first and second quarters of 2024, marking a significant milestone in the relationship between Reflect Scientific and the buyer. The transaction highlights the growing demand for Reflect Scientific's innovative technologies and the trust major industry players have in their products, such as the T-90 Storage Freezer and T-160 Ultra Low Freezer. The sale reaffirms Reflect Scientific's commitment to providing reliable freezing solutions to the pharmaceutical industry.
FAQ
What is the current stock price of Reflect Scientfc (RSCF)?
What is the market cap of Reflect Scientfc (RSCF)?
